Cat. No. 218 011BT |
100 µg purified IgG, lyophilized, labeled with
Biotin.
For reconstitution add 100 µl H2O to get a 1mg/ml solution in PBS. Then aliquot and store at -20°C to -80°C until use. Antibodies should be stored at +4°C when still lyophilized. Do not freeze! |
Applications |
IP: not tested yet ICC: not tested yet IHC: 1 : 400 (see remarks) IHC-P: 1 : 100 ELISA: yes (see remarks) |
Label | biotin |
Clone | 2-48 |
Subtype | IgG1 (κ light chain) |
Immunogen | Synthetic peptide corresponding to AA 3 to 7 from human Abeta-pE3 (UniProt Id: P05067) |
Reactivity |
Reacts with: human (P05067), rat (P08592), mouse (P12023). Other species not tested yet. |
Specificity | Specific for Abeta-pE3. |
Remarks |
IHC: Antigen retrieval with formic acid is required. |
Data sheet | 218_011bt.pdf |
Amyloid deposits, also called plaques, of Alzheimer's patients consist of several protein components like the amyloid beta-peptides (Abeta, Aβ) 1-40/42 and additional C- and N-terminally truncated and modified fragments. Very abundant are the isoaspartate (isoAsp)-Abeta and pyroglutamyl (pGlu)-Abeta peptides. The latter are formed by cyclization of the N-terminal glutamate at position 3 or 11 catalyzed by glutaminyl cyclase (QC) resulting in very amyloidogenic and neurotxic variants of Abeta; Abeta-pE3 and Abeta pE11.
In contrast to extracellular plaques that do not perfectly correlate with Alzheimer´s disease intraneuronal Abeta accumulation and vascular Abeta deposits have gained more and more evidence to be among the crucial factors responsible for progressive neuron loss.